UnitedHealth Group (UNH)
309.00
+0.13 (0.04%)
NYSE · Last Trade: Jun 18th, 2:06 PM EDT
Detailed Quote
Previous Close | 308.87 |
---|---|
Open | 307.55 |
Bid | 308.95 |
Ask | 309.05 |
Day's Range | 306.70 - 311.79 |
52 Week Range | 248.88 - 630.73 |
Volume | 6,491,761 |
Market Cap | 281.19B |
PE Ratio (TTM) | 12.94 |
EPS (TTM) | 23.9 |
Dividend & Yield | 8.400 (2.72%) |
1 Month Average Volume | 20,220,078 |
Chart
About UnitedHealth Group (UNH)
UnitedHealth Group is a leading diversified health and well-being company that provides a wide range of health care products and services. The company operates through two main segments: UnitedHealthcare, which offers health insurance and health services to individuals and businesses, and Optum, which delivers pharmacy care, health management, and technology solutions. UnitedHealth Group focuses on enhancing health care access, improving health outcomes, and optimizing costs through integrated care solutions and data-driven insights. With a commitment to innovation and quality, the company aims to help people live healthier lives while making the health care system work better for everyone. Read More
News & Press Releases
Healthcare stocks are lagging the market by the widest margin since 2008. Analysts and valuation trends point to a rebound.
Via Benzinga · June 18, 2025
Hims & Hers Health shares rocketed higher over the last year, rewarding investors.
Via The Motley Fool · June 18, 2025
Via The Motley Fool · June 18, 2025
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via StockStory · June 18, 2025
Shares of UnitedHealth Group have sold off considerably this year, as bad news surrounding the company continues to pile up.
Via The Motley Fool · June 17, 2025
UnitedHealth began 2025 with a sharp divergence between underlying business growth and overall performance, prompting a significant negative market reaction. Management attributed the quarter’s shortfall mainly to a faster-than-expected rise in care activity within its Medicare Advantage segment and unforeseen changes in member profiles at Optum Health. CEO Andrew Witty described the results as “unusual and unacceptable,” highlighting that more frequent physician and outpatient visits—especially among group retirees facing premium hikes—drove costs higher than anticipated. Additionally, complexity in adapting to new CMS risk model changes hampered operational execution and revenue recognition.
Via StockStory · June 17, 2025
Via The Motley Fool · June 17, 2025
Abbott Laboratories has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 17.8% and now trades at $133.43. This performance may have investors wondering how to approach the situation.
Via StockStory · June 17, 2025
The draft Senate bill introduces stricter work requirements and funding curbs for Medicaid, while shelving proposed Medicare cuts that could have impacted major insurers.
Via Stocktwits · June 16, 2025
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired UnitedHealth securities between December 3, 2024 and April 16, 2025, both dates inclusive (the “Class Period”). Investors have until July 7, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Bragar Eagel & Squire · Via GlobeNewswire · June 16, 2025
Several major large-cap stocks, each with a market capitalization of over $30 billion, have recently announced notable increases to their quarterly dividends. These updates, aligned with recent shareholder meetings and strategic decisions, reflect efforts to enhance shareholder value and demonstrate financial strength.
Via MarketBeat · June 16, 2025
Via Benzinga · June 16, 2025
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · June 16, 2025
Rob Sechan recommends buying Alphabet Inc on CNBC's Halftime Report Final Trades, citing its strong performance and low price. Ericsson and Alphabet teamed up for new software platform. NB Private Wealth's CIO picks iShares U.S. Energy ETF. Schlumberger, UnitedHealth also mentioned.
Via Benzinga · June 16, 2025
These two S&P 500 stocks, which fell between 18.2% and 26.6% in May, are worth watching.
Via The Motley Fool · June 15, 2025
The Dow Jones index could have fared better in May if not for these two stocks.
Via The Motley Fool · June 14, 2025
Via The Motley Fool · June 14, 2025
UnitedHealth Group's recent dividend boost and strategic divestiture efforts, combined with executive stock purchases, highlight its strong investment appeal.
Via MarketBeat · June 13, 2025
Via Benzinga · June 13, 2025
Via The Motley Fool · June 12, 2025
Via The Motley Fool · June 12, 2025